Tag: Bruce Cozadd

Axsome Therapeutics to acquire Sunosi from Jazz Pharmaceuticals

pallavi123- March 29, 2022

Axsome Therapeutics has agreed to acquire Sunosi (solriamfetol), an approved dual-acting dopamine and norepinephrine reuptake inhibitor (DNRI), from Jazz Pharmaceuticals. Sunosi is indicated to improve ... Read More

Jazz Pharmaceuticals gets Rylaze FDA approval for ALL and LBL

pallavi123- July 3, 2021

Rylaze FDA approval : Jazz Pharmaceuticals has secured approval for its leukemia drug Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn or JZP458) from the US Food and ... Read More

Jazz Pharmaceuticals to acquire Epidiolex developer GW Pharmaceuticals for $7.2bn

pharmanewsdaily- February 3, 2021

Irish biopharma company Jazz Pharmaceuticals has agreed to acquire British pharma company GW Pharmaceuticals in a cash-cum-stock deal worth $7.2 billion. Upon closing of the ... Read More